Diabetes mellitus is a risk factor for the development of gastroparesis. Currently, metoclopramide is the only US FDA-approved medication for the treatment of gastroparesis. However, the FDA ...
Metoclopramide use during early pregnancy was not associated with excess risk for congenital malformations. In the U.S., treatment of nausea and vomiting during early pregnancy usually involves ...
Oral metoclopramide is available generically. Eli Lilly ( LLY ) and Novo Nordisk ( NVO ) are currently the leading marketers of GLP-1 drugs for diabetes and weight loss. More on Evoke Pharma ...